Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding - PubMed (original) (raw)
. 1997 May 1;158(9):4237-44.
Affiliations
- PMID: 9126985
Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding
X Tao et al. J Immunol. 1997.
Abstract
The adaptive immune responses to foreign Ags are primarily regulated by the cytokines produced by CD4 T cells. The generation of distinct cytokine-producing T cell subsets has been shown to be influenced by a number of factors, including cytokines, different types of APCs, and the amounts of priming Ag. We have previously reported that the affinity of an antigenic peptide for its presenting MHC class II molecules and that different doses of Ag peptide affect the outcome of the functional CD4 T cell response. In the current study, we further examined the impact of the affinity of an antigenic peptide for its TCR on CD4 T cell priming. We generated a panel of Ag peptide variants mutated at positions known to be critical for binding to a well-characterized TCR (known as altered peptide ligands, or APLs). Compared with the WT peptide, these APLs are defective in stimulating the proliferative responses of T cells. However, they can effectively prime in vitro naive CD4 T cells for differentiation into both Th1-like and Th2-like cells. In contrast, the WT peptide primes only for IFN-gamma-producing Th1-like cells. Using highly purified dendritic cells as APCs to present the APL or WT peptide leads to the same pattern of priming as using total splenic APCs. These results indicate that priming by APLs for both IL-4 production and IFN-gamma production does not require two different types of APCs. In summary, our data indicate that APL can directly stimulate naive CD4 T cells to become Th2 effector cells.
Similar articles
- The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, Nakada M, Tokunaga T, Xu W, Kariyone A, Saito T, Kitamura T, Maxwell G, Takaki S, Takatsu K. Tamura T, et al. Int Immunol. 2004 Dec;16(12):1691-9. doi: 10.1093/intimm/dxh170. Epub 2004 Oct 11. Int Immunol. 2004. PMID: 15477229 - Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.
Constant SL, Bottomly K. Constant SL, et al. Annu Rev Immunol. 1997;15:297-322. doi: 10.1146/annurev.immunol.15.1.297. Annu Rev Immunol. 1997. PMID: 9143690 Review. - Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
Nishimura Y, Chen YZ, Kanai T, Yokomizo H, Matsuoka T, Matsushita S. Nishimura Y, et al. Intern Med. 1998 Oct;37(10):804-17. doi: 10.2169/internalmedicine.37.804. Intern Med. 1998. PMID: 9840700 Review.
Cited by
- How do I steer this thing? Using dendritic cell targeted vaccination to more effectively guide the antitumor immune response with combination immunotherapy.
Linch SN, Redmond WL. Linch SN, et al. J Immunother Cancer. 2016 Jun 21;4:31. doi: 10.1186/s40425-016-0135-z. eCollection 2016. J Immunother Cancer. 2016. PMID: 27330804 Free PMC article. - OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.
Linch SN, McNamara MJ, Redmond WL. Linch SN, et al. Front Oncol. 2015 Feb 16;5:34. doi: 10.3389/fonc.2015.00034. eCollection 2015. Front Oncol. 2015. PMID: 25763356 Free PMC article. Review. - Attenuated T cell responses to a high-potency ligand in vivo.
Corse E, Gottschalk RA, Krogsgaard M, Allison JP. Corse E, et al. PLoS Biol. 2010 Sep 14;8(9):e1000481. doi: 10.1371/journal.pbio.1000481. PLoS Biol. 2010. PMID: 20856903 Free PMC article. - Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment.
Yamane H, Zhu J, Paul WE. Yamane H, et al. J Exp Med. 2005 Sep 19;202(6):793-804. doi: 10.1084/jem.20051304. J Exp Med. 2005. PMID: 16172258 Free PMC article. - High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection.
Ahlers JD, Belyakov IM, Thomas EK, Berzofsky JA. Ahlers JD, et al. J Clin Invest. 2001 Dec;108(11):1677-85. doi: 10.1172/JCI13463. J Clin Invest. 2001. PMID: 11733563 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous